Skip to main content

Advertisement

Log in

Donepezil Eliminates Suppressive Effects of β-Amyloid Peptide (1-42) on Long-Term Potentiation in the Hippocampus

  • Biophysics and Biochemistry
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

β-Amyloid peptide 1-42 in a concentration of 200 nM impairs induction of long-term posttetanic potentiation of population spike in CA1 pyramidal neurons in rat hippocampal slices. Application of donepezil, a drug used for the treatment of Alzheimer disease, in a concentration of 1 μM eliminates the suppressive effect of β-amyloid peptide 1-42 on long-term posttenanic potentiation in the hippocampus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. H. Hsieh, J. Boehm, C. Sato, et al., Neuron, 52, No. 5, 831–843 (2006).

    Article  CAS  PubMed  Google Scholar 

  2. K. Kato, H. Hayako, Y. Ishihara, et al., Neurosci. Lett., 260, No. 1, 5–8 (1999).

    Article  CAS  PubMed  Google Scholar 

  3. J. H. Kim, R. Anwyl, Y. H. Suh, et al., J. Neurosci., 21, No. 4, 1327–1333 (2001).

    CAS  PubMed  Google Scholar 

  4. M. Kimura, S. Akasofu, H. Ogura, and K. Sawada, Brain Res., 1047, No. 1, 72–84 (2005).

    Article  CAS  PubMed  Google Scholar 

  5. T. Kume, M. Sugimoto, Y. Takada, et al., Eur. J. Pharmacol., 527, Nos. 1–3, 77–85 (2005).

    Article  CAS  PubMed  Google Scholar 

  6. J. Meunier, J. Ieni, and T. Maurice, Br. J. Pharmacol., 149, No. 8, 998–1012 (2006).

    Article  CAS  PubMed  Google Scholar 

  7. S. Moriguchi, X. Zhao, Marszalec W., et al., J. Pharmacol. Exp. Ther., 315, No. 1, 125–135 (2005).

    Article  CAS  PubMed  Google Scholar 

  8. C. Pereira, P. Agostinho, P. I. Moreira, et al., Curr. Drug Targets CNS Neurol. Disord., 4, No. 4, 383–403 (2005).

    Article  CAS  PubMed  Google Scholar 

  9. S. L. Rogers, R. S. Doody, R. S. Mohs, and L. T. Friedhoff, Arch. Intern. Med., 158, No. 9, 1021–1031 (1998).

    Article  CAS  PubMed  Google Scholar 

  10. D. J. Selkoe, Science, 298, 789–791 (2002).

    Article  CAS  PubMed  Google Scholar 

  11. E. I. Solntseva, J. V. Bukanova, E. Marchenko, and V. G. Skrebitsky, Comp. Biochem. Physiol. C. Toxicol. Pharmacol., 144, No. 4, 319–326 (2007).

    Article  PubMed  Google Scholar 

  12. J. B. Standridge, Clin. Ther., 26, No. 5, 615–630 (2004).

    Article  CAS  PubMed  Google Scholar 

  13. R. D. Terry, E. Masliah, and D. P. Salmon, Ann. Neurol., 30, No. 4, 572–580 (1991).

    Article  CAS  PubMed  Google Scholar 

  14. Q. Wang, D. M. Walsh, M. J. Rowan, et al., J. Neurosci., 24, No. 13, 3370–3378 (2004).

    Article  CAS  PubMed  Google Scholar 

  15. L. Ye and J. T. Qiao, Neurosci. Lett., 275, No. 3, 187–190 (1999).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. I. Solntseva.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 149, No. 1, pp. 38–41, January, 2010

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kapai, N.A., Solntseva, E.I. & Skrebitskii, V.G. Donepezil Eliminates Suppressive Effects of β-Amyloid Peptide (1-42) on Long-Term Potentiation in the Hippocampus. Bull Exp Biol Med 149, 33–36 (2010). https://doi.org/10.1007/s10517-010-0868-5

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-010-0868-5

Key Words

Navigation